Clinical Medical Transformation Center

OriCell Therapeutics has established strategic cooperation with a number of domestic grade-A tertiary hospitals, combined with its own R&D experience in the field of solid tumor immunotherapy, to allow researchers, doctors, and patients to gather under one roof, establish a bridge between basic research and clinical application, and promote the transformation of clinical medicine in the field of solid tumor immunotherapy.

  • Shanghai General Hospital

    Shanghai Engineering Technology Research Center for Cell Therapy Clinical Research and Transformation

    Clinical research on TIL cells for treatment of malignant bone tumors

    Clinical research on CAR-T cells and screening of related new targets

  • Zhongshan Hospital

    Zhongshan OriCell Cell Therapy Center

    Conduct IND clinical trials on immunocytotherapy for advanced liver cancer

  • Lishui Central Hospital

    Cell Therapy Clinical Research and Transformation Center

    Conduct non-IND clinical research on immunocytotherapy for advanced liver cancer

  • Changzheng Hospital

    Changzheng OriCell Clinical Cell Research Center

    Clinical research on TIL cells for treatment of malignant bone tumors

    Clinical research on CAR-T cells and screening of related new targets

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    Conduct non-IND/IND clinical trials on CAR-T cell therapy for target site-2 in myeloma

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Conduct non-IND clinical trials on immunocytotherapy for advanced liver cancer

1 >>